Skip to search.
 TSX Down 0.55% TSX Ventures Down 1.35%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
33.10 Down 1.89(5.40%) May 4, 4:00PM EDT
Prev Close:34.99
Open:34.78
Bid:32.12 x 100
Ask:33.00 x 100
1y Target Est:42.62
Beta:1.94278
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:33.10 - 35.05
52wk Range:26.02 - 52.33
Volume:1,063,404
Avg Vol (3m):1,260,280
Market Cap:4.64B
P/E (ttm):N/A
EPS (ttm):-0.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENDown 5.40%4.64B
IMGNUp 0.98%537.17M
PFEDown 0.89%206.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.09
Quarterly EPS Est (Jun-16) :-0.31
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-1.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback